Friday, February 21, 2020 7:35:29 AM
Negativity had nothing to do with getting 8's; there isn't any new blood investing in BIEL, and the market is simply reflecting its complete lack of faith in the company. Full FDA clearance and this couldn't even break .0015, or a half billion in shares traded on the day of the PR.
If news clearly won't move the needle any longer, then only revenue and profits will, and with the latest shareholder update cautioning on the time it takes to ink these deals, those two things are further off than a quarter or two from now. BIEL is likely to continue churning in the .0007-.0012 range for many, many more days.
Historical dilution, bloated share structure, flippers and notes holders selling, and no faith in the company - that's why the PPS is floundering on what should have been momentous news for the share price.
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM